- Medicines and Related Substances Act (101/1965): Regulations: Transparent pricing system for medicines and scheduled substances: Information to be provided by manufacturers and or importers of medicines and related substances for the single exit price adjustment for the year 2012 (Gazette No. 34959 – Regulation 48)0.92 MB
Ms MP Matsoso, Director-General: Health, have determined in accordance with Regulation 21 of the Regulations Relating to a Transparent Pricing System for Medicines and Related Substances published in Government Gazette Number 28214 of 11 November 2005 that the following information must be submitted to the Directorate: Pharmaceutical Economic Evaluation (PEE) within the National Department of Health by a manufacturer or importer of the medicine or scheduled substance.
EMAIL THIS ARTICLE SAVE THIS ARTICLE FEEDBACK
To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here
